Trial · NCT01858532
Adverse events2,394
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,394
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | Enrichment Atrasentan | 180 | 5,107 | 183 |
| other | ANAEMIA | Blood and lymphatic system disorders | Double-Blind Atrasentan | 216 | 1,829 | 241 |
| other | ANAEMIA | Blood and lymphatic system disorders | Double-Blind Placebo | 127 | 1,830 | 138 |
| other | DIARRHOEA | Gastrointestinal disorders | Enrichment Atrasentan | 103 | 5,107 | 108 |
| other | DIARRHOEA | Gastrointestinal disorders | Double-Blind Atrasentan | 99 | 1,829 | 116 |
| other | DIARRHOEA | Gastrointestinal disorders | Double-Blind Placebo | 103 | 1,830 | 110 |
| other | OEDEMA PERIPHERAL | General disorders | Enrichment Atrasentan | 1,148 | 5,107 | 1,273 |
| other | OEDEMA PERIPHERAL | General disorders | Double-Blind Atrasentan | 534 | 1,829 | 765 |
| other | OEDEMA PERIPHERAL | General disorders | Double-Blind Placebo | 483 | 1,830 | 666 |
| other | NASOPHARYNGITIS | Infections and infestations | Enrichment Atrasentan | 145 | 5,107 | 152 |
| other | NASOPHARYNGITIS | Infections and infestations | Double-Blind Atrasentan | 180 | 1,829 | 274 |
| other | NASOPHARYNGITIS | Infections and infestations | Double-Blind Placebo | 169 | 1,830 | 278 |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Enrichment Atrasentan | 110 | 5,107 | 114 |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Double-Blind Atrasentan | 106 | 1,829 | 131 |
| other | UPPER RESPIRATORY TRACT INFECTION | Infections and infestations | Double-Blind Placebo | 114 | 1,830 | 140 |
| other | URINARY TRACT INFECTION | Infections and infestations | Enrichment Atrasentan | 50 | 5,107 | 51 |
| other | URINARY TRACT INFECTION | Infections and infestations | Double-Blind Atrasentan | 93 | 1,829 | 126 |
| other | URINARY TRACT INFECTION | Infections and infestations | Double-Blind Placebo | 93 | 1,830 | 135 |
| other | HYPERKALAEMIA | Metabolism and nutrition disorders | Enrichment Atrasentan | 77 | 5,107 | 77 |
| other | HYPERKALAEMIA | Metabolism and nutrition disorders | Double-Blind Atrasentan | 132 | 1,829 | 159 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01858532/events